Skip to main content
Print Save

UPSHER-SMITH 150 mg Pill - gray & yellow capsule/oblong, 11mm

Pill with imprint UPSHER-SMITH 150 mg is Gray & Yellow, Capsule/Oblong and has been identified as Topiramate Extended-Release 150 mg. It is supplied by Upsher-Smith Laboratories, Inc.

Topiramate is used in the treatment of Migraine Prevention; Lennox-Gastaut Syndrome; Epilepsy; Seizures; Seizure Prevention and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for UPSHER-SMITH 150 mg

Topiramate extended-release 150 mg UPSHER-SMITH 150 mg
Topiramate extended-release 150 mg UPSHER-SMITH 150 mg

Topiramate Extended-Release

Imprint
UPSHER-SMITH 150 mg
Strength
150 mg
Color
Gray & Yellow
Size
11.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Upsher-Smith Laboratories, Inc.
Inactive Ingredients
microcrystalline cellulose, hypromellose 2910 (6 mPa.s), ethylcellulose (10 mPa.s), diethyl phthalate, titanium dioxide, ferrosoferric oxide, ferric oxide yellow

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00832-1075 Upsher-Smith Laboratories Inc.
00245-1075 Upsher-Smith Laboratories Inc.
Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Related images for "UPSHER-SMITH 150 mg"

Pill UPSHER-SMITH 150 mg Yellow & Gray Capsule/Oblong is Qudexy XR
Qudexy XR

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer